The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials

Blood Adv. 2022 Jan 11;6(1):225-227. doi: 10.1182/bloodadvances.2021006473.

Cristina Bagacean^{1

2}, Jean-Christophe Ianotto¹, Nanthara Sritharan³, Florence Cymbalista⁴, Christian Berthou^{1

2}, Vincent Lévy^{3

5}

¹ Department of Hematology, CHU Brest, Brest, France.
² Department of Hematology, Université de Brest, INSERM, UMR1227, Lymphocytes B et Auto-immunité, Brest, France.
³ Département de Recherche Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France.
⁴ Laboratoire d'Hématologie, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France; and.
⁵ CRESS UMR 1153 ECSTRRA team, INSERM, Paris, France.

No abstract available

MeSH terms